Continuous development of arrhythmia is observed in swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant)

Liver Transplantation

Volumn 17, Issue 2, 2011, Pages 122-128

  Okamoto, Sadahisa ^a,b   Hörnsten, Rolf ^d   Obayashi, Konen ^c   Wijayatunga, Priyantha ^a   Suhr, Ole B ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

ADULT; AGED; ARTICLE; DISEASE COURSE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENE MUTATION; HEART ARRHYTHMIA; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; SWEDEN;

ADULT; AGE OF ONSET; AGED; AMYLOID NEUROPATHIES, FAMILIAL; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION; PREALBUMIN; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79551501879     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22184     Document Type: Article

References (29)

1. Andersson R,. Familial amyloidosis with polyneuropathy. a clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976; 590: 1-64.
2. Benson MD,. Amyloidosis. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 1995: 4159-4191.
3. Ando Y, Nakamura M, Araki S,. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62: 1057-1062.
4. Suhr O, Danielsson A, Holmgren G, Steen L,. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994; 235: 479-485.
5. Monteiro E, Freire A, Barroso E,. Familial amyloid polyneuropathy and liver transplantation. J Hepatol 2004; 41: 188-194.
6. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113-1116.
7. Suhr OB, Ericzon BG, Friman S,. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002; 8: 787-794.
8. Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, et al. Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients' survival. Liver Transpl 2009; 15: 1229-1235.
9. Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 2007; 7: 2597-2604. (Pubitemid 47561612)
10. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000; 274: 702-706.
11. Liepnieks JJ, Benson MD,. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007; 14: 277-282.
12. Okamoto S, Yamashita T, Ando Y, Ueda M, Misumi Y, Obayashi K, et al. Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation. Intern Med 2008; 47: 2133-2137.
13. Olofsson BO, Backman C, Karp K, Suhr OB,. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002; 73: 745-751.
14. Hornsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB,. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004; 78: 112-116.
15. Hornsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB,. Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 2010; 17: 63-68.
16. Engel G, Beckerman JG, Froelicher VF, Yamazaki T, Chen HA, Richardson K, et al. Electrocardiographic arrhythmia risk testing. Curr Probl Cardiol 2004; 29: 365-432.
17. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P,. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008; 216: 253-261.
18. Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004; 63: 129-138.
19. Beckman A, Bjerle P, Olofsson BO,. Electrocardiographic findings in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1992; 6: 192-196.
20. Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006; 85: 229-238.
21. Wiklund U, Hornsten R, Olofsson BO, Suhr OB,. Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy. Auton Neurosci 2010; 156: 124-130.
22. de Freitas AF,. The heart in Portuguese amyloidosis. Postgrad Med J 1986; 62: 601-605.
23. Hongo M, Yamamoto H, Kohda T, Takeda M, Kinoshita O, Uchikawa S, et al. Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings. Am J Cardiol 2000; 85: 849-853.
24. Hornsten R, Wiklund U, Suhr OB, Jensen SM,. Ventricular late potentials in familial amyloidotic polyneuropathy. J Electrocardiol 2006; 39: 57-62.
25. Rapezzi C, Riva L, Quarta CC, Perugini E, Salvi F, Longhi S, et al. Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid 2008; 15: 40-48.
26. Suhr OB, Lindqvist P, Olofsson BO, Waldenstrom A, Backman C,. Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy. Amyloid 2006; 13: 154-159.
27. Johansson B, Westermark P,. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991; 32: 83-92.
28. Westermark P, Bergstrom J, Solomon A, Murphy C, Sletten K,. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003; 10 (suppl 1): 48-54.
29. Ando Y, Yonehara T, Tanaka Y, Tashima K, Uchino M, Ando M,. Early pacemaker implantation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 1996; 19: 1640-1641.